“…Consistently with this assumption, MTH1-knockout mice showed a higher incidence of lung, liver and stomach cancer (Tsuzuki et al, 2001a;2001b). However, no mutations or polymorphisms in the hMTH1 gene were found to be correlated with hereditary nonpolyposis colorectal cancer (HNPCC) (Wu et al, 1995), acute childhood leukemia (Lin et al, 1998b), hepatocellular carcinoma, lung cancer (Oda et al, 1999), ovarian cancer (Takama et al, 2000), familial adenomatous polyposis (FAP), sporadic colorectal cancer (Sieber et al, 2003;Kim et al, 2004), nor with Parkinson's disease (Satoh & Kuroda, 2000). Similarly, no such correlation was found in the rat 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)induced mammary carcinomas, which showed an elevated level of AT→CG transversions (Okochi et al, 2002a;2002b).…”